Author:
Ji Y.D.,Johnson D.N.,Faquin W.C.,Peacock Z.S.
Subject
Otorhinolaryngology,Oral Surgery,Surgery
Reference19 articles.
1. Identification of recurrent SMO and BRAF mutations in ameloblastomas;Sweeney;Nat Genet,2014
2. Cost and lack of insurance coverage are prohibitive to having dental implants after resections for benign mandibular neoplasms;Peacock;Oral Surg Oral Med Oral Pathol Oral Radiol,2017
3. High frequency of BRAF V600E mutations in ameloblastoma;Kurppa;J Pathol,2014
4. Roche Diagnostics. Roche receives FDA clearance for the VENTANA MMR IHC Panel for patients diagnosed with colorectal cancer. 〈https://diagnostics.roche.com/es/es/news-listing/2017/roche-receives-fda-clearance-for-the-ventana-mmr-ihc-panel-for-p1.html〉, [Accessibility verified June 1, 2023].
5. Ameloblastoma: a clinical review and trends in management;McClary;Eur Arch Otorhinolaryngol,2016